News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

BioPharm Executive - Legal Briefs
Horizon Biopharm Pulls Out of $2 Billion Hostile Takeover Bid for Depomed (DEPO) After Court Ruling 11/20/2015
FDA Wants to Shut Down the Loophole that Theranos Used But Some Politicians Don't Get Why 11/19/2015
New Lawsuit Accuses Sanofi (SNY) of Intentionally Delaying MS Drug Development to Avoid $708 Million in Payments 11/11/2015
Mallinckrodt (MNK) Plunges After Citron Claims Next Victim in Tweet 11/11/2015
Feds Investigate Eli Lilly (LLY), Merck & Co. (MRK) Over Drug Pricing Policies 11/9/2015
AbbVie (ABBV)'s Pain is Gilead (GILD)'s Gain After FDA Slaps Warning on AbbVie’s Hepatitis Drugs 10/26/2015
More Scandal Clouds Valeant (VRX) as Committee is Formed to Review Accounting Practices; Conference Call to be Held Today 10/26/2015
Imprimis (immy) Offers $1 Alternative to Turing Pharma's $750 AIDS Drug 10/23/2015
Valeant (VRX) Investigated By Feds for Its Drug Pricing Practices; Faces Multiple Subpoenas 10/15/2015
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For ALT-P7, An Antibody-Drug Conjugate Targeting HER2 With Alteogen 10/12/2015
Court Orders CEO of Fake Spencer Pharma to Pay Bilked Investors $7 Million 10/5/2015
Turing Pharma Becomes Political Football, Donald Trump Weighs In 9/25/2015
Clinton Promises Prescription Drug Price Cap, Sends Biotech Stocks Plummeting 9/23/2015
TetraPhase (TTPH) Executive Profits Off Stock Sale Hours Before Company Announces Clinical Trial Failure, Report Says 9/15/2015
Novartis AG (NVS) Takes on Amgen (AMGN) With Launch of the First U.S. Biosimilar 9/4/2015
FDA Warns Merck & Co. (MRK), AstraZeneca PLC (AZN) and Boehringer Ingelheim About Joint Pain With Diabetes Drugs 9/2/2015
Amgen (AMGN) Will Hand Over $71 Million to Settle Drug Promotion Claims 8/20/2015
Novartis AG (NVS) Reports Third Case of PML in Relapsing MS Patient Treated with Gilenya 8/19/2015
Retrophin (RTRX) Sues Ousted CEO Martin Shkreli for $65 Million 8/17/2015
FDA Denied: Federal Judge Grants Amarin (AMRN) Permission to Promote Fish Oil Drug 8/10/2015
Watchdog Accuses Pfizer (PFE) of Overcharging By Millions for Epilepsy Drug 8/6/2015
Noted Biotech Investor Steven Burrill Sued for Theft of $17.6 Million from Fund 7/15/2015
Novartis AG (NVS) Researchers ID Possible Link Between GlaxoSmithKline (GSK) Flu Vaccine, Narcolepsy 7/6/2015
Novo Nordisk A/S (NVO) Pulls Tresiba Off Shelves in Germany 7/2/2015
Feds Want Novartis AG (NVS) to Fork Over $3.35 Billion for Kickback Schemes 7/1/2015
Cipla Executives Resigning, But Company Says Nothing Amiss 6/22/2015
BIO2015 EXCLUSIVE: Biosimilars Are the "Future of Affordable Healthcare," Pfenex (PFNX) CEO Tells BioSpace (DHX) 6/18/2015
Alnylam (ALNY) Slaps Dicerna (DRNA) With Trade Secret Lawsuit 6/11/2015
GlaxoSmithKline (GSK) Investigator Caught Up in China Bribery Scandal Released From Prison Early 6/10/2015
Pfizer (PFE) Report Shows Scientist Warned Execs About Zoloft Risks Last Year 6/10/2015
Court Blocks Novartis AG (NVS)'s Recently Approved "Biosimilar" Form of Amgen (AMGN)'s Neupogen 5/11/2015
Pfizer (PFE) Agrees to Pay Off Parkinson Patients Who Developed Gambling and Sex Addiction While On Cabaser 5/11/2015
Amarin (AMRN) Enlists Top Lawyer to Sue the FDA Over First Amendment Rights 5/8/2015
Johnson & Johnson (JNJ) Taps Ethicists to Weigh Compassionate Use Requests 5/7/2015
Texas Psychiatrists Accused of Accepting Bribes from AstraZeneca PLC (AZN) to Manipulate State Formulary 4/24/2015
In Largest Settlement Of Its Kind, Teva (TEVA) Will Pay $512 Million to Resolve Pay-to-Delay Case 4/21/2015
Pfizer (PFE) Victorious in First Trial Over Zoloft Birth Defect Claims 4/20/2015
Patient Dies Using Drug With Active Ingredients Like Biogen (BIIB)'s Tecfidera 4/13/2015
Amgen (AMGN) Devastated as Novartis AG (NVS) Wins Approval to Sell First-of-a-Kind Copycat Drug 3/24/2015
Nektar Therapeutics (NKTR) Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry 3/20/2015
Ex-Workers Accuse Novartis AG (NVS)'s Alcon (ACL) of Being Sexist, Maintaining a Boy's Club Atmosphere 3/19/2015
Johnson & Johnson (JNJ) Unit Pleads Guilty for Knowingly Selling Tainted Children's Tylenol 3/12/2015
GlaxoSmithKline (GSK) to Fire 110 Staffers in China for Violating Policy 3/6/2015
Neigbors Sue Roche (RHHBY) for Being Negligent With Handling of Hazardous Chemicals That Contaminated Land 3/6/2015
Gilead (GILD) Agrees to a Discounted Price of $46,000 for Sovaldi in Europe 2/13/2015
Hedge Fund Manager Picks Acorda Therapeutics (ACOR) as His First Victim Against the Pharmaceutical Industry and Its "BS" Patents 2/12/2015
AstraZeneca PLC (AZN) to Shell Out $7.9 Million in Kickback Scandal 2/12/2015
Ex-Merck & Co. (MRK) Analyst Facing Insider Trading Charges to Plead Guilty 2/10/2015
Merck & Co. (MRK) Scientist Threatened with Jail Time for Trying to Expose Huge Vaccine Data Manipulation and Fraud 2/9/2015
After Gilead (GILD)-AbbVie (ABBV)'s Hep C Price War, Express Scripts Inc. Eyes Cancer Meds Next 1/23/2015
Gilead (GILD)'s India Patent Roadblock May Spur More Sovaldi Copies 1/15/2015
J.P. Morgan: AstraZeneca PLC (AZN) CEO Says He's Not Worried About Pricing Pressure 1/15/2015
Targets Of Next Express Scripts Inc. Price War: Amgen (AMGN) and Regeneron (REGN) 1/14/2015
More Trouble for Retrophin (RTRX) Founder 1/9/2015
Gilead Sciences, Inc. (GILD) Sued Over Outrageous Hepatitis C Drug Prices 12/15/2014
Pfizer (PFE)'s Antipsychotic Geodon Could Cause Fatal Skin Reaction: FDA 12/15/2014
Zydus Cadila Launches World's First Biosimilar Of AbbVie (ABBV)'s Humira In India 12/9/2014
Novartis AG (NVS) Fires Scientist Who Falsified Data In 6 Research Papers 12/1/2014
Ex-Retrophin (RTRX) CEO Sold Stock While Urging Investors To Buy 11/26/2014
U.S. Court Overturns Bid By India's Ranbaxy Laboratories (RANBAXY.BO) To Block Launch Of Rival Generic Drugs 11/20/2014
Forward Pharma (FWP) Sues Biogen Idec (BIIB) Over Tecfidera Sales In Germany 11/18/2014
AbbVie (ABBV) Uses Patents To Ambush Gilead (GILD) 11/14/2014
Major Medical Centers Ask Congress To Probe Genentech (RHHBY)'s Distribution Changes 11/13/2014
Amgen (AMGN), Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst 10/31/2014
Tug-Of-War Over Revlimid Patent Continues Between Celgene (CELG), Natco Pharma Limited 10/24/2014
New AbbVie (ABBV) Head Blasts Canada’s Patent Laws On Drugs 10/24/2014
Amgen (AMGN) Files Lawsuit Against Sanofi (SAN.PA) And Regeneron (REGN) For Patent Infringement 10/17/2014
Lawyers Have Documents That Prove Allergan Inc. (AGN) Misled Investors About Valeant (VRX): Ackman 10/17/2014
Largest Biotech IPO Yet Could Be Derailed By Forward Pharma (FWP), Biogen Idec (BIIB) Patent Fight 10/15/2014
Chinese Court Hits GlaxoSmithKline (GSK) With $492M Bribery Fine 9/19/2014
FDA Panel Backs Limits On Testosterone Drugs 9/17/2014
AbbVie (ABBV), Teva Pharmaceutical Industries Limited (TEVA) Illegally Blocked Generic Version Of AndroGel: Federal Trade Commission 9/9/2014
Bristol-Myers Squibb Company (BMY) Takes Immunotherapy Rivalry With Merck & Co. (MRK) To The Courts 9/8/2014
Gilead (GILD) Close To Inking Deal That Would Bring Low-Cost Versions Of $84,000 Solvadi Drug To Poor Countries 9/5/2014
Pfizer Inc. (PFE) Is Liable For Harm Caused By A Generic Rival: Court 8/18/2014
Eisai Company, Ltd. (ESALY.PK) Sues The FDA To Regain "Lost" Marketing Time For Its Drugs 8/18/2014
AbbVie (ABBV) Decides Against Appealing A Ruling That Would Have Protected Gays 8/8/2014
As Pfizer Inc. (PFE) Settles Rapamune, Another Wave Of Lipitor Lawsuits Hit 8/8/2014
Pfizer Inc. (PFE) To Shell Out $35 Million To NC, Other States For Rapamune 8/7/2014
Amgen (AMGN) Nervous As FDA Paves Way For Novartis AG (NVS) To Copy Drug Neupogen 7/28/2014
Boehringer Ingelheim GmbH Withheld Evidence On Blockbuster Blood Thinner 7/24/2014
Pfizer (PFE) Fights Off Shareholder Lawsuit 7/9/2014
Novartis AG (NVS) Issues New Research Guidelines After Japan Study Scandal 7/8/2014
GlaxoSmithKline (GSK) Risks Being Thrown Out Of China 7/7/2014
FDA Finally Proposes Social Media Guidelines For Drugmakers 6/18/2014
UK's Cost Agency Not Ready To Back Gilead Sciences, Inc. (GILD)'s Controversial Hepatitis C Drug 6/17/2014
Italy To Fund Unapproved Use Of Roche (RHHBY) Drug To Cut Costs; Move Startles The Industry 6/13/2014
Pfizer Inc. (PFE) To Pay $325 Million In Neurontin Settlement 6/3/2014
GlaxoSmithKline (GSK) Dodged Millions In China Drug Tax Scam 5/20/2014
SEC Accuses Two Doctors Of Insider Trading After GTx, Inc. (GTXI) Clinical Trial Is Halted 5/20/2014
Jury Finds For Takeda Pharmaceutical Co. Ltd. (TKPYY) In Diabetes Drug Case 5/16/2014
Eli Lilly and Company (LLY) Loses Major Patent Case To Actavis (ACT) 5/16/2014
Mylan Inc. (MYL) Applauds Court's Ruling Dismissing Teva Pharmaceutical Industries Limited (TEVA)'s Suit Against FDA On Copaxone® 5/15/2014
Ex-Sanofi (France) (SAN.PA) Executive Gets 16 Months For Insider Trading 4/21/2014
Astellas Pharma Inc. (ALPMY) Makes $7.3 Million Deal With U.S. Department Of Justice 4/17/2014
GlaxoSmithKline (GSK) Can't Catch A Break, Faces Bribery Allegations In Poland 4/14/2014
Roche (RHHBY), Novartis AG (NVS) Offices Raided Over Wet AMD Treatments 4/11/2014
Verdict In: Jury Orders Takeda Pharmaceutical Co. Ltd. (TKPYY), Eli Lilly and Company (LLY) To Pay $9 Billion In Damages Over Actos 4/8/2014
Gilead Sciences, Inc. (GILD)'s $84,000 Treatment Questioned By U.S. Lawmakers 3/25/2014
Johnson & Johnson (JNJ) Gets $1.2 Billion Risperdal Judgment Tossed Out 3/21/2014
Business Bill Could Help Scientists Let Go By Pfizer Inc. (PFE) 3/19/2014
FDA Commissioner Defends Zogenix, Inc. (ZGNX)'s Pain Drug As Criticism Intensifies 3/14/2014
Pfizer Inc. (PFE) Faces Earlier Celebrex Competition After Ruling, Vows To Appeal 3/13/2014
Maybe There Is Such A Thing As A Free Lunch - Vermont Considers Allowing Drug And Device Makers To Again Provide In-Office Meals To Healthcare Professionals 2/20/2014
Pfizer Inc. (PFE) Legal Exec Predicts Government Clampdown On CEO Quotes, Press Releases 2/14/2014
Boehringer Ingelheim Corporation Facing 2,000+ U.S. Lawsuits Over Blood Thinner 2/13/2014
Ex-SAC Trader Convicted Of Seeking Out Secrets Related To Experimental Alzheimer's Drug 2/7/2014
Abbott Laboratories (ABT) Labs Sued By Five Men Claiming Androgel Injuries 2/7/2014
Teva Pharmaceutical Industries Limited (TEVA) Asks Supreme Court To Review Copaxone Ruling 1/23/2014
Doc Admits He Leaked Secret ALZ's Trial Information To "Friend" At SAC 1/21/2014
Actavis (ACT) To Exit China As Unfriendly Government Not Worth It 1/17/2014
Gentium S.p.A. Shareholders Sue Over $1 Billion Jazz Pharmaceuticals plc (JAZZ) Deal 1/17/2014
Whistleblower Lawsuit Costs Genzyme Corporation (GENZ) $22 Million 1/6/2014
U.S. Supreme Court Refuses To Hear Ex-InterMune, Inc. (ITMN) CEO's Appeal 12/16/2013
GlaxoSmithKline (GSK) Paper At Center Of Fabricated Data Scandal Is Retracted 12/9/2013
Reckitt Benckiser Pharmaceuticals Inc. Pharma Unit In The U.S. Is Raided By The Feds 12/9/2013
European Court May Force AbbVie (ABBV), InterMune, Inc. (ITMN) To Release Business Secrets 12/6/2013
Apotex Inc. Ordered To Pony Up $76 Million To AstraZeneca PLC (AZN) In Damages 12/4/2013
U.S. Supreme Court Rejects Teva Pharmaceutical Industries Limited (TEVA)'s Copaxone Petition 11/14/2013
Sanofi (SAN.PA) Files "First-Of-A-Kind" Lawsuit Against FDA Over OTC Drug 11/13/2013
FDA Slaps Aegerion Pharmaceuticals, Inc. (AEGR) CEO For "Serious" Violations Of Drug Promotion Law Following CNBC Interview 11/11/2013
Amarin Corporation PLC (AMRN) Appeals FDA Rescission of Special Protocol Agreement 11/8/2013
U.S. Appeals Court Revives Patent Fight Over AstraZeneca PLC (AZN) Drug 10/31/2013
Ex-Bristol-Myers Squibb Company (BMY) Executive Gets One Year in Prison for Insider Trading 10/24/2013
BioReference Laboratories, Inc. (BRLI) Sued by Myriad Genetics, Inc. (MYGN), Confident in Its Position 10/22/2013
Quest Diagnostics Inc. (DGX) Debuts Cheaper Genetic Test to Challenge Rival Myriad Genetics, Inc. (MYGN) 10/15/2013
Supreme Court Rejects Novartis AG (NVS) Bid to Hear Punitive Damages Case 10/8/2013
U.S. Court Lifts Ban on Competitor to AstraZeneca PLC (AZN)'s Nexium 10/2/2013
Sanofi (France) (SAN.PA) Settles Lawsuit Over Obesity Drug for $40 Million 9/20/2013
Eli Lilly and Company (LLY) Files $500 Million Lawsuit Against Canada 9/13/2013
Mold Prompts Recall of 5,000 Vials of Johnson & Johnson (JNJ)'s Schizophrenia Drug 9/13/2013
GlaxoSmithKline (GSK) Declines as FDA Clears Path for Advair Rivals, $8 Billion in Revenue Threatened 9/10/2013
Eli Lilly and Company (LLY) "Concerned" by China Bribery Allegations 9/10/2013
Federal Trade Commission Submits Proposed Amicus Brief Concerning "No-Authorized-Generic" Commitments in Drug Companies' Patent Settlements 8/20/2013
A Takeda Pharmaceutical Co. Ltd. (TKPYY) Manager Asks the Supreme Court to Review a Whistleblower Ruling 8/15/2013
OxyContin Maker, Purdue Pharma Won't Share List of Suspicious Doctors 8/13/2013
FDA Ordered to Cough Up Docs Regarding Gilead Sciences, Inc. (GILD) Drug 8/8/2013
India Revokes GlaxoSmithKline (GSK) Cancer Drug Patent in Latest Big Pharma Blow 8/2/2013
Biogen Idec, Inc. (Massachusetts) (BIIB): It's Unlikely Patient Death Was Caused by New MS Drug 7/24/2013
Novartis AG (NVS) Admits 2 Ex-Employees Plus Prominent Japanese Doc Involved in Data Scandal 7/23/2013
GlaxoSmithKline (GSK) Says Executives Appear to Have Broken Chinese Law 7/22/2013
Drugmaker Fees for FDA Review Would be Freed in U.S. House Bill 7/19/2013
SEC Comes Calling for AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) as FDA Panel Fallout Continues 7/12/2013
EU Fines H. Lundbeck A/S (LUN.CO) and Others $195 Million for Blocking Rival Drugs 6/19/2013
Novartis AG (NVS) Sacks 18 for Fabricating Sales Data 6/14/2013
The Supreme Court Rules Out Some - But Not All -- Gene Patents 6/13/2013
Another GlaxoSmithKline (GSK) Scandal in China: Bribing Docs to Prescribe Meds? 6/13/2013
Teva Pharmaceutical Industries Limited (TEVA), Sun Pharmaceutical Industries Ltd to Pay $2.15 Billion to Settle Pfizer Inc. (PFE) Patent Suit 6/12/2013
Sanofi (France) (SAN.PA) Fined $52 Million Over Plavix Smear Campaign in France 5/14/2013
Ranbaxy Laboratories (RANBAXY.BO) Pays $500 Million to Settle Long-Running Production Scandal 5/14/2013
Fired Exec Claims ReSearch Pharmaceutical Services (RPS), Inc. Violated Privacy Practices in Hiring 5/13/2013
Sanford Heisler Files $100 Million+ Discrimination Suit Against Pharma Giant Merck & Co., Inc. (MRK) 5/9/2013
Former Johnson & Johnson (JNJ) Employee Sues Over Age Discrimination 5/9/2013
Bayer AG (BAYN.DE) Patent on Yaz Birth Control Pill Ruled Invalid 4/18/2013
Amgen (AMGN) to Pay $25 Million to Settle Kickback Allegations 4/17/2013
Eli Lilly and Company (LLY) Settles Wrongful Death Lawsuit 4/10/2013
AstraZeneca PLC (AZN) Suffers Fresh Drug Patent Setback in U.S. 4/2/2013
Novartis AG (NVS) Loses Cancer Drug Glivec Patent Case 4/1/2013
Syntrix Wins $96 Million Verdict Against Illumina, Inc. (ILMN) in DNA Patent Suit 3/15/2013
Federal Trade Commission Slams Actelion Pharmaceuticals US, Inc. (ATLN.VX) for Withholding Samples 3/13/2013
Merck & Co., Inc. (MRK) Hid Fosamax's Bone-Weakening Risks, Lawyer Contends 3/13/2013
Interpol, Dozens of Drug Makers Ramp Up Fight Against Counterfeit Drugs 3/12/2013
AbbVie (ABBV) Seeks to Block Release of Clinical Trial Data 3/11/2013
Royalty Deal May Settle Lawsuit Over InterMune, Inc. (ITMN) Lung Drug 2/20/2013
Express Scripts Inc. Says Ernst & Young LLP Stole Secrets 2/20/2013
U.S. Appeals Court Finds AstraZeneca PLC (AZN)'s Seroquel XR Patent Infringed 2/15/2013
Merck & Co., Inc. (MRK) to Pay $688 Million to Settle Enhance Lawsuits 2/14/2013
Eli Lilly and Company (LLY) Threatens to Leave Canada Over Patent Rulings 2/14/2013
Otsuka Can Block Generic Abilify as Court Rejects Appeal 1/15/2013
Amgen (AMGN) Whistleblower Fights to Unseal Documents 1/15/2013
Pfizer Inc. (PFE) Can be Sued for Injury Caused by Generic 1/14/2013
Teva Pharmaceutical Industries Limited (TEVA) Asks FDA Not to Approve Biogen Idec, Inc. (Massachusetts) (BIIB) MS Drugs 1/14/2013
Eli Lilly and Company (LLY) May Have a $15 Billion "Wild Card" Up Its Sleeve: Analysis 1/7/2013
Servier Founder Faces Manslaughter Charges 12/14/2012
Pfizer Inc. (PFE) to Pay $55 Million to Settle Protonix Case 12/13/2012
Boehringer Ingelheim Corporation Sued by Hundreds Over Bleeding Tied to Pradaxa 12/11/2012
KV Pharmaceutical to Pay Hologic, Inc. (HOLX) $60 Million to Settle Makena Drug Dispute 12/11/2012
The Op-Ed: Johnson & Johnson (JNJ) Patent Move is "Inadequate" 11/30/2012
GlaxoSmithKline (GSK) Pays $90 Million to Settle States' Avandia Claims 11/16/2012
GlaxoSmithKline (GSK) Employee Blows Whistle on Drug Promotions 11/13/2012
Tiny Tekmira Pharmaceuticals Corporation Lands $65 Million Settlement Plus $10 Million in Near-Term Milestone Payments From Alnylam Pharmaceuticals (ALNY) 11/13/2012
Girl Dies as Pluristem Therapeutics (PSTI) Sells on Gains With Miracle Cells 11/9/2012
Johnson & Johnson (JNJ) Settles 845 Levaquin Lawsuits 11/2/2012
FDA Warns Celltex Therapeutics Corporation Over Violations 10/17/2012
Pfizer Inc. (PFE) to Shell Out $164 Million in Investor Lawsuit Over Celebrex 10/10/2012
Johnson & Johnson (JNJ) Loses a Preemption Case Over Infant Tylenol 10/10/2012
SEC Investigates Pfizer Inc. (PFE) Over Odd Results 10/9/2012
FDA: New England Compound Center Drugs Tied to Meningitis 10/8/2012
Johnson & Johnson (JNJ) CEO Dodges Bullet in Risperdal Drug Case 9/21/2012
Johnson & Johnson (JNJ) Settles Risperdal Side Effect Lawsuit 9/11/2012
Use of Gilead Sciences, Inc. (GILD) Stribild HIV Pill May be Limited in U.S. 9/10/2012
India Court Rules for Cipla Ltd. Against Roche (RHHBY) in Patent Case 9/10/2012
VIVUS, Inc. (VVUS) Tumbles on Concerns About Generic Qsymia 8/21/2012
Myriad Genetics, Inc. (MYGN) Wins Gene Patent Ruling From US Appeals Court 8/17/2012
Gilead Sciences, Inc. (GILD) Warned by Democrats Over "Quad" Pricing 8/16/2012
Pfizer Inc. (PFE) to Pay $60 Million for Making Foreign Bribes 8/8/2012
U.S. Appeals Court Tosses Momenta Pharmaceuticals, Inc. (MNTA) Injunction Against Generic Lovenox 8/6/2012
VIVUS, Inc. (VVUS) Diet Pill Patents are Questioned and Stock Sinks 7/23/2012
U.S. Charges 48 People in $500 Million Medicaid Drug Scheme 7/18/2012
Merck & Co., Inc. (MRK)'s Schering-Plough Corporation (SGP)'s K-Dur Pay-for-Delay Ruling Reversed 7/17/2012